Pharmagenerics represents a large group of manufacturers, enabling the company to make suitable and competitive proposals for every product or product group. In addition, Pharmagenerics has exclusive agreements with:

BOEHRINGER INGELHEIM, an international, innovative pharmaceutical company. Pharmagenerics has been the exclusive agent and distributor of the pharmachemical division of Boehringer Ingelheim since 2003. This division is represented by Pharmagenerics in Poland, Slovenia, Croatia, Serbia, Macedonia, Bosnia & Herzegovina, Bulgaria and Romania.

SANOFI, a leading international pharmaceutical company. CEPiA Sales is a Sanofi division dedicated to manufacturing and supply of a broad range of API. Pharmagenerics has been the exclusive agent of Sanofi's CEPiA division for Hormones and Steroids in numerous countries in Central Europe. The API on offer are all accompanied by sufficient regulatory support.

Pharmathen, focuses on the development and marketing of pharmaceuticals and has a strong position in generic licensing. Pharmathen develops around 10 dossiers per year, which are available for out-licensing.

Fujian Fukang Pharmaceutical Corp. Ltd. is a premium producer of Gentamycin Sulphate manufactured in an EU-certified facility supported by a CEP.
Pharmagenerics is the largest stockholder in the EU of this API.